Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Awareness Technology, Inc.

Awareness Technology, Inc. provides clinical laboratory instrumentation, reagents and assays for small-to-medium-volu... read more Featured Products: More products

Download Mobile App





Awareness Technology Showcases Range of Cutting-Edge Analyzers

By LabMedica International staff writers
Posted on 12 Nov 2024

Awareness Technology, Inc. More...

(Palm City, FL, USA) is showcasing its advanced analyzers at MEDICA 2024 where these instruments are available for hands-on demonstrations during the show.

At this year’s MEDICA, Awareness is presenting the ChemWell 2 two-plate ELISA/chemiluminescent analyzer for running a variety of applications. The instrument’s ability to mix a wide range of ELISA/CLIA assays on two microwell plates provides a level of flexibility that makes the ChemWell 2 an excellent choice for laboratories. Awareness is also showcasing the ChemWell RPR Automated RRP Analyzer for serum syphilis screening that utilizes a sophisticated camera system designed to capture high-resolution images of the reactions. It features specialized software that analyzes the image, providing an accurate and objective reading of the reaction as reactive or non-reactive.

Also being presented at the show are the enhanced Stat Fax 4500 biochemistry analyzer and Stat Fax 4700 ELISA strip reader which have recently received upgraded screens, faster processors, and new user interfaces. At the heart of the Stat Fax 4500 and 4700 is a new and faster micro-processor and significantly increased memory capacity. All the calculation modes, reporting functions, and the ability to customize test parameters remain the same but function faster. A new feature of the instruments’ improved memory capacity is their ability to store over 140 programmed tests. Their new interface features a high-resolution backlit display with a capacitive touch screen that has the responsiveness of a smartphone with no need for a stylus to make accurate selections. Screens are updated almost instantly with a new menu system driven by icons designed to intuitively identify their functions.

At MEDICA 2024, Awareness is also introducing its latest instrument, the Chemi+ biochemistry analyzer designed to optimize laboratory efficiency. This compact device boasts a small footprint, making it an ideal choice for labs with limited space. The Chemi+ is complemented by user-friendly software, ensuring seamless operation for lab technicians of all skill levels. A standout feature of the Chemi+ is its open system capability, which allows for wireless management of up to four Chemi+ analyzers through a single tablet or PC. This integration not only simplifies workflow but also enhances productivity by enabling simultaneous multi-device operation. The Chemi+ biochemistry analyzer is poised to set a new standard in laboratory technology, combining efficiency, ease of use, and advanced connectivity in a compact design.

Related Links:
Awareness Technology, Inc.


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
LAIR2 Antibody Pair Set
LAIR2 Antibody Pair [Biotin]
New
Microbiology Laboratory Automation Solution
BD Kiestra™ ReadA+BarcodA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Tracking blood test trends alongside unexplained weight loss may help identify patients at increased cancer risk and support earlier investigation (Image Credit: 123RF)

Blood Test Patterns Improve Cancer Risk Assessment in Primary Care

Unexplained weight loss is a common but nonspecific presentation in primary care that can precede several types of cancer, making referral decisions difficult. Routine blood tests may produce borderline... Read more

Molecular Diagnostics

view channel
Image: NTM are about 200 environmental bacteria found in soil and water that can cause chronic, tuberculosis-like lung infections but are distinct from the Mycobacterium tuberculosis complex (Image Credit: Adobe Stock)

Rapid CRISPR Test Identifies Nontuberculous Mycobacteria Species from Respiratory Samples

Chronic lung infections caused by nontuberculous mycobacteria (NTM) are increasingly recognized but frequently mistaken for tuberculosis, complicating diagnosis and care. These infections may affect as... Read more

Immunology

view channel
Image: Although many people harbor latent Epstein-Barr virus (EBV), growing evidence has linked the virus to MS pathobiology (Image Credit: Adobe Stock)

Blood EBV Activity Biomarkers May Predict Multiple Sclerosis Relapse Months Ahead

Predicting relapse in multiple sclerosis (MS) remains difficult, limiting opportunities for timely intervention and monitoring. Although many people harbor latent Epstein-Barr virus (EBV), growing evidence... Read more

Microbiology

view channel
Image: Graphical Abstract (Jose A. Céspedes, Maria I. Montañez, Isabel M. Jiménez, et al. Magnetic nanoparticles enable clinically relevant in vitro diagnosis of beta-lactam allergy. Materials Today Bio (2026). DOI: 10.1016/j.mtbio.2026.103356)

Magnetic Nanoparticles Enable More Sensitive Beta-Lactam Allergy Testing

Penicillin allergy labels are common in clinical practice, yet many are incorrect and can lead to suboptimal antibiotic choices. Although 8%–25% of people report a penicillin allergy, only 1%–10% are truly... Read more

Pathology

view channel
Image Credit: Adobe Stock

Machine Learning Cytology Tool Improves Cancer Cell Identification

Cytological screening remains central to early cancer detection, but its accuracy depends heavily on expert interpretation of stained cells. Under conventional microscopy, malignant and reactive cells... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image: The acquisition adds Convergent Genomics’ UroAmp platform and proprietary urinary tumor DNA technology to Veracyte’s portfolio (Photo courtesy of Convergent Genomics)

Veracyte Acquisition Expands Urine-Based Bladder Cancer Monitoring Capabilities

Veracyte, Inc. has acquired Convergent Genomics, expanding its urology diagnostics offerings with the company’s UroAmp platform and proprietary urinary tumor DNA (utDNA) technology. UroAmp has been clinically... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.